1.Lenders WJ, Duh QY, Eisenhofer G, et al; Endocrine Society. (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 99:1915–1942. doi: 10.1210/jc.2014–1498.
2.Cotesta D, Petramala L, Serra V, et al. (2009) Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press Cardiovasc Prev. 16:183–193. doi: 10.2165/11530430–000000000–00000.
3.Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. (2011) Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 29:2049–2060. doi: 10.1097/HJH.0b013e32834a4ce9.
4.Zelinka T, Petrák O, Turková H, et al. (2012) High incidence of cardiovascular complications in pheochromocytoma. Horm Metab Res. 44:379–384. doi: 10.1055/s–0032–1306294.
5.Olmati F, Petramala L, Bisogni V, et al. (2018) A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor. Medicine (Baltimore) 97:e13369. doi: 10.1097/MD.0000000000013369.
6.Streeten DH, Anderson GH Jr. (1996) Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens. 9:760–769. DOI: 10.1016/0895–7061(96)00057-x.
7.Hannah-Shmouni F, Pacak K, Stratakis CA. (2017) Metanephrines for Evaluating Palpitations and Flushing. JAMA. 318:385–386. doi: 10.1001/jama.2017.5926.
8.Thosani S, Ayala-Ramirez M, Román-González A, et al. (2015) Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. Eur J Endocrinol. 173:377–387. doi: 10.1530/EJE–15–0456.
9.Royo P, de Luis E, Manero MG, Velloso MJ, Toledo G, Alcázar JL. (2007) Pelvic paraganglioma. J Ultrasound Med. 26:261–265.
10. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. Jul 21;339:b2700. doi:10.1136/bmj.b2700.
10.Plouin PF, Gimenez-Roqueplo AP. (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis. 1:49. DOI: 10.1186/1750–1172–1–49.
11.Wick RM. (2000) Neuroendocrine neoplasia. Current concepts. Am J Clin Pathol. 113:331–335. DOI: 10.1309/ETJ3-QBUK–13QD-J8FP
12.Priyadarshi V and Pal DK. (2015) Paraganglioma of urinary bladder. Urol Ann. 7:402–404. doi: 10.4103/0974–7796.152058.
13.Zimmerman IJ, Biron RE, Macmahon HE. (1953) Pheochromocytoma of the urinary bladder. N Engl J Med. 249:25–26. DOI: 10.1056/NEJM195307022490106.
14.Yi C, Han L, Yang R, et Yu J. (2017) Paraganglioma of the renal pelvis: a case report and review of literature. Tumori. 103:e47-e49.
15.Amulya S, Dhar YG, Manjushree S, Arvind S. (2017) Extra-adrenal retroperitoneal paraganglioma: report of a rare case. J Clin Diagn Res. 2:146–147. doi: 10.7860/JCDR/2014/10133.5138.
16.Cao G, Mendez J, Navacchia D. (2017) Malignant extra-adrenal pelvic paraganglioma in a pediatric patient. Ecancermedicalscience. 11:761. doi: 10.3332/ecancer.2017.761.
17.Tsai CC, Wu WJ, Chueh KS, et al. (2011) Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures. Kaohsiung J Med Sci. 27:108–113. doi: 10.1016/j.kjms.2010.05.005.
18.Geng JH, Huang SP, Shen JT, et al. (2014) Paraganglioma of the urinary bladder with pelvic metastases. Urological Science. 25;91–94.
19.Chang Y, Chiang I, Chen CH, et al. (2015) Paragangliomas of the urinary bladder: A report of 6 cases and review of the literature. Urological Science. 26:111–114.
20.Dattatrya JY, Vedpalsingh TH, Ravikant SU, et al. (2015) Paraganglioma of Urinary Bladder Presenting as An Early Preeclampsia with Successful Perinatal Outcome After Surgery: A Case Report and Review of Literature. J Clin Diagn Res. 9:PDO1-PD02. doi: 10.7860/JCDR/2015/14306.6420.
21.Demirkesen O, Cetinel B, Yaycioglu O, et al. (2000) Unusual cause of early preeclampsia: bladder paraganglioma. Urology. 56:154.
22.Parmar K, Chandna A, Kumar S. (2019) Retroperitoneal paraganglioma: a chameleon masquerading as an adrenal pheochromocytoma. Ann R Coll Surg Engl. 101:e62-e65. doi: 10.1308/rcsann.2018.0193.
23.Beilan J, Lawton A, Hajdenberg J, Rosser CJ. (2013) Locally advanced paraganglioma of the urinary bladder: a case report. BMC Res Notes. 6:156. doi: 10.1186/1756–0500–6–156.
24.Pedroso C, Robalo R, Sereno P, et al. (2015) A rare abdomino-pelvic tumor: paraganglioma. Acta Medica Port. 28:114–116.
25.Di Daniele N, Canale MP, Tesauro M, et al. (2012) Preoperative embolization reduces the risk of catecholamine release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma. Case Rep Endocrinol. 481328. doi: 10.1155/2012/481328.
26.Kumar S, Parmar KM, Prasad S, Rani J. (2014) Malignant Pelvic Pheochromocytoma Presenting as Non Functioning Kidney and Accelerated Hypertension: A Rare Presentation. Case Rep Nephrol. 985615.
27.El Khoury F, Jour I, Malaeb B, Assaf G. (2012) Bladder paraganglioma. A case report. J Med Liban. 60:182–184.
28.Cai Y, Li HZ, Zhang YS. (2015) Successful Treatment of Coexisting Paraganglioma of the Retroperitoneum and Urinary Bladder by Intermediate-Dose 131I-MIBG Therapy: A Case Report. Medicine (Baltimore) 94:e1686. doi: 10.1097/MD.0000000000001686.
29.de Paula Miranda E, Lopes RI, Padovani GP, et al. (2016) Malignant paraganglioma in children treated with embolization prior to surgical excision. World J Surg Oncol. 14:26. doi: 10.1186/s12957–016–0778–8.
30.Imperatore V, Creta M, Di Meo S, et al. (2017) Incidentally discovered pelvic paraganglioma: A case report. Arch Ital Urol Androl. 89:319–320. DOI: 10.4081/aiua.2017.4.319
31.Persec Z, Buković D, Persec J, et al. (2012) Paraganglioma of the urinary bladder—clinicopathological, immunohistochemical and electron microscopy analysis—a case report. Coll Antropol. 36:1041–1043.
32.Kuscu E, Oktem M, Eroglu D, et al. (2005) Pelvic retroperitoneal paraganglioma mimicking an ovarian mass. Eur J Gynaecol Oncol. 26:219–220.
33.Kumar S, Parmar KM, Singh S, Rani J. (2014) Pelvic pheochromocytoma mimicking as urinary bladder pheochromocytoma: looking beyond the obvious. J Clin Imaging Sci. 4:56. doi: 10.4103/2156–7514.143409.
34.Rayamajhi SJ, Mittal BR, Shukla J, et al. (2015) Recurrent Urinary Bladder Paraganglioma Detected on 68Ga DOTANOC PET/CT. Clin Nucl Med. 40:e490–491. doi: 10.1097/RLU.0000000000000910.
35.Lacefield E, Raheem OA, Cox R, et al. (2015) Composite Paraganglioma and Neuroblastoma of the Urinary Bladder: A Rare Histopathological Entity. Curr Urol. 8:208–211. doi: 10.1159/000365718.
36.Lin WC, Wang HY, Chang CW, et al. (2012) Retroperitoneal paraganglioma manifesting as paralytic ileus: a case report. J Med Case rep. 6:158. doi: 10.1186/1752–1947–6–158.
37.Shah VB, Bhandare AT. (2015) A rare case of malignant paraganglioma of urinary bladder. Indian J Pathol Microbiol. 58:235–237. doi: 10.4103/0377–4929.155329.
38.Kumar S, Pragatheeswarane M, Sharma AP, et al. (2017) Expanding the horizon of robotic surgery to large pelvic paraganglioma. J Robot Surg. 11:247–250. doi: 10.1007/s11701–016–0648-y.
39.Taue R, Takigawa H, Sinotou K, et al. (2001) A case of pelvic malignant paraganglioma. Int J Urol. 8:715–718.
40.Thambugala GM, Fulham MJ, Mohamed A. (2007) Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma. Australas Radiol 51:B45-B47. DOI: 10.1111/j.1440–1673.2007.01846.x
41.Vellar ID, Chmiel R, Cahill J. (1978) Localization of a phaeochromocytoma situated in the pelvis by radionuclide scanning. Br J Surg. 65:25–26.
42.Athyal RP, Al-Khawari H, Arun N, et al. (2007) Urinary bladder paraganglioma in a case of von Hippel-Lindau disease. Australas Radiol. 51:B67–70. DOI: 10.1111/j.1440–1673.2007.01758.x
43.Adejimi O. Adeniji, MD. (2009) Urinary bladder pheochromocytoma. Applied Radiology.
44.Onishi T, Sakata Y, Yonemura S, Sugiumura Y. (2003) Pheochromocytoma of the urinary bladder without typical symptoms. Int J Urol. 10:398–400.
45.F. Doran, S. Varinli, Y. Bayazit, et al. (2002) Pheochromocytoma of the urinary bladder. APMIS. 110:733–736.
46.Chen YC, Su YC, Tzang JE, et al. (2009) A woman with persistent chest pain and palpitations after coronary stenting. Kidney Int. 75:1361–1362. doi: 10.1038/ki.2009.120.
47.Zhou M, Epstein JI, Young RH. (2004) Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol. 28:94–100.
48.Shono T, Sakai H, Minami Y, et al. (1999) Paraganglioma of the urinary bladder: a case report and review of the Japanese literature. Urol Int. 62:102–105. DOI: 10.1159/000030367.
49.Sanjoaquin M, Fraile J, Gutierrez A, et al. (2000) Hypertensive crisis during a transurethral resection of the bladder: non diagnosed bladder paraganglioma. Anesth Analg. 90:556–558.
50.Baima C, Casetta G, Vella R, Tizzani A. (2000) Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB). Urol Int. 65:176–178. DOI: 10.1159/000064868.
51.Bhalani SM, Casalino DD, Manvar AM. (2011) Paraganglioma of the bladder. J Urol. 186:279.280. DOI: 10.1016/j.juro.2011.04.032.
52.De Pasquale V, Magistrelli A, Diomedi Camassei F, Caione P. (2011) Unusual bladder mass in a 14-year old boy: bladder paraganglioma. Urol Int. 86:117–120. doi: 10.1159/000320840.
53.Mun K, Pailoor J, Chan KS, Pillay B. (2009) Extra-adrenal paraganglioma: presentation in three uncommon locations. Malays J Pathol. 31:57–61.
54.Kang SS, Kang SH, Choi H, et al. (2011) Robot Assisted Partial Cystectomy of a Bladder Pheochromocytoma. Urol Int. 81:241–244. doi: 10.1159/000324269.
55.Naguib M, Caceres M, Thomas CR Jr, et al. (2002) Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol. 25:42–44.
56.Yoshida S, Nakagomi K, Goto S, Kobayashi S. (2004) Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. Int J Urol. 11:175–177.
57.Kovacs K, Bell D, Gardiner GW, et al. (2005) Malignant paraganglioma of the urinary bladder: immunohistochemical study of prognostic indicators. Endocr Pathol. 16:363–369.
58.Zwahlen D, Fishman PN, Honey J, et al. (2007) Malignant pheochromocytoma of the urinary bladder. Can J Urol. 14:3455–3457.
59.Huang KH, Chung SD, Chen SC, et al. (2007) Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute. Int J Urol. 14:181–185. DOI: 10.1111/j.1442–2042.2007.01687.x.
60.Havekes B, Corssmit EP, Jansen JC, et al. (2007) Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocr Metab. 92:1245–1248. DOI: 10.1210/jc.2006–1993.
61.Darlong V, Pandey R, Garg R, et al. (2012) Perioperative concerns of recurrent urinary bladder phaeochromocytoma with skeletal metastasis. Singapore Med J. 52:e40–41.
62.Manohar K, BR Mittal, A. Bhattacharya, et al. (2012) A rare case of malignant urinary bladder paraganglioma with distant metastases demonstrated by 18F-FDG PET/CT. Clin Nucl Med. 37:e148-e149. DOI: 10.1097/RLU.0b013e318238f71a.
63.Feng N, Li X, Gao H, et al. (2013) Urinary bladder malignant paraganglioma with vertebral metastasis: a case report with review of the literature. Chin J Cancer. 32:624–628. DOI: 10.5732/cjc.012.10317.
64.Maeda M, Funahashi Y, Katoh M, et al. (2013) Malignant bladder pheochromocytoma with SDHB genetic mutation. Aktuelle Urol. 44:381–382. DOI: 10.1055/s–0033–1345147.
65.Gkikas C, Ram M, Tsafrakidis P. (2016) Urinary Bladder Paraganglioma and Concomitant Metastatic Lung Cancer. A Case Report. Urol Case Rep. 5:17–19. DOI:10.1016/j.eucr.2015.12.002.
66.You D, Ren R, Chen E, et al. (2016) Radiotherapy for urinary bladder pheochromocytoma with invasion of the prostate: A case report and literature review. Mol Clin Oncol. 4:1060–1062. DOI: 10.3892/mco.2016.820.
67.Sherwani P, Anand R, Narula MK, et al. (2015) Concurrent nonfunctional paraganglioma of the retroperitoneum and urinary bladder: A case report with literature review. Indian J Radiol Imaging. 25:198–201. DOI: 10.4103/0971–3026.155879.
68.Peng C, Bu S, Xiong S, et al. (2015) Non-functioning paraganglioma occurring in the urinary bladder: A case report and review of the literature. Oncol Lett. 10:321–324. DOI: 10.3892/ol.2015.3222.
69.Lazareth H, Cohen D, Vasiliu V, et al. (2017) Paraganglioma of the bladder in a kidney transplant recipient: A case report. Mol Clinl Oncol. 6:553–555. DOI: 10.3892/mco.2017.1182.
70.Henderson SJ, Kearns PJ, Tong CMC et al. (2015) Patients With Urinary Bladder Paragangliomas: A Compiled Case Series From a Literature Review for Clinical Management. Urology. 85:e25-e29. DOI: 10.1016/j.urology.2014.11.006.
71.Mahjoubi Z, BehRhouma S, Bibi M, et al. (2018) Atypical calcified paraganglioma of the urinary bladder: A new case report. Urol Case Rep. 20:108–110. DOI: 10.1016/j.eucr.2018.07.024.
72.A. Mithqal, P. Darvishi, P. Rehm. (2017) MIBG Localization of a Subclinical Paraganglioma of the Bladder. Clin Nucl Med. 42:e196-e198. DOI: 10.1097/RLU.0000000000001562.
73.Iwamoto G, Kawahara T, Tanabe M, et al. (2017) Paraganglioma in the bladder: a case report. J Med Case Rep. 11:306. DOI: 10.1186/s13256–017–1473–2.
74.Spessoto LC, Vasilceac FA, Padilha TL, et al. (2016) Incidental Diagnosis of Nonfunctional Bladder Paraganglioma. Urol Case Rep. 4:53–54. DOI: 10.1016/j.eucr.2015.09.007.
75.El-Tholoth HS, Al Rasheedi S, Alharbi F, et al. (2018) Paraganglioma of Urinary Bladder Managed by Laparoscopic Partial Cystectomy in Conjunction with Flexible Cystoscopy: A Case Report. J of Endourol Case Rep. 4:15–17. DOI: 10.1089/cren.2017.0132.
76.Srirangalingam U, Banerjee A, Patki P, et al. (2017) Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas. Clin Genitourin Cancer. 15:131–136. DOI: 10.1016/j.clgc.2016.06.006
77.Quist EE, Javadzadeh BM, Johannesen E, et al. (2015) Malignant paraganglioma of the bladder: A case report and review of the literature. Pathol Res Pract. 211:183–188. DOI: 10.1016/j.prp.2014.10.009.
78. Stigliano A, Lardo P, Cerquetti L, et al. (2018) Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation. A case report. Medicine (Baltimore). 97:e10904. DOI: 10.1097/MD.0000000000010904.
79.Verma A, Pandey D, Akhtar A, et al. (2015) Non-Functional Paraganglioma of Retroperitoneum Mimicking Pancreatic Mass with Concurrent Urinary Bladder Paraganglioma: An Extremely Rare Entity. J Clin Diagn Res. 9:XD09-XD11. DOI: 10.7860/JCDR/2015/11156.5570.
80.Williams P, Siref L, Feloney M. (2017) Pheochromocytoma of the bladder. JAAPA. 3023–25. DOI: 10.1097/01.JAA.0000522134.68445.50.
81.Gyftopoulos K, Perimenis P, Ravazoula Z, et al.. (2000) Pheochromocytoma of the Urinary Bladder Presenting Only with Macroscopic Hematuria, Urol Int. 65:173–175. DOI: 10.1159/000064867.
82.Yadav S, Banerjee I, Tomar V, Yadav SS. (2016) Pelvic paraganglioma: a rare and unusual clinical presentation of paraganglioma. BMJ Case Rep. pii:bcr2015212851. DOI: 10.1136/bcr–2015–212851.
83.Bohn OL, Pardo-Castillo E, Fuertes-Camilo M, et al. (2001) Urinary Bladder Paraganglioma in Childhoold: A case Report and Review of the Literature. Pediatr Dev Pathol. 14:327–332. DOI: 10.2350/10–10–0926-CR.1.
84.Pastor-Guzmàn, S. Lòpez-Garcìa, J. M. Giménez-Bachs, et al. (2004) Paraganglioma of the bladder: controversy regarding treatment. Urol Int. 73:270–274. DOI: 10.1159/000080841.
85.Beilan JA, Lawton A, Hajdenberget J, Rosser CJ. (2013) Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC urology. 13:22. DOI: 10.1186/1471–2490–13–22.
86.Petramala L, Galassi M, D’ermo G, et al. (2017) Nonfunctioning adrenal pheochromocytoma incidentally discovered associated with renal oncocytoma. Journal of Onco-Nephrology. 1:62–65. DOI: 10.5301/jo-n.5000003.
87. Brito JP, Asi N, Gionfriddo MR, et al. (2015) The incremental benefit of functional imaging in pheochromocytoma/parganglioma: a systematic review. Endocrine. 50(1):176–86. doi: 10.1007/s12020–015–0544–7.
88.Williams TA, Lenders JW, Mulatero P, et al. (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5:689–699. DOI: 10.1016/S2213–8587(17)30135–3